BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«ASTRAZENECA

Below is an extended ASTRAZENECA patents listing. Click here to return to the ASTRAZENECA main Biocorporate entry.

ASTRAZENECA Patents :

US Patent No.Title
7396834 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
7411074 Process and intermediates for the preparation of the thienopyrrole derivatives
7416865 Process for the preparation of dihydroxy esters and derivatives thereof
7417049 Furyl compounds
7417050 Heterocyclic compounds
7419788 Method for screening anti-bacterial agents
7419979 Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-- one
7420003 Compounds and a novel process for their preparation
7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors
7423061 Substitute thiophenes and uses thereof
7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
7411070 Form of S-omeprazole
7410972 Compounds
7396847 Oxazolidinone and/or isoxazoline as antibacterial agents
7399780 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3
7402585 Substituted quinazoline derivatives as inhibitors of aurora kinases
7402604 Positive modulators of nicotinic receptor agonists
7405211 Therapeutic morpholino-substituted compounds
7407946 Quinazoline compounds
7407968 Compounds
7408064 Carbazole derivatives and their use as NPY5 receptor antagonists
7408065 P2X.sub.7 receptor antagonists and their use
7410966 Use of and some novel imidazopyridines
7425556 Compounds and uses thereof
7425560 Thioxanthine derivatives as myeloperoxidase inhibitors
7449446 Combination product comprising melagatran and dexamethasone
7449475 Tricyclic spiropiperidines or spiropyrrolidines
7449489 Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists
7456160 Formulation
7456200 Compounds
7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
7462623 Quinazoline derivatives as Src tyrosine kinase inhibitors
7462644 Therapeutic agents
7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
7465795 Compounds and uses thereof
7446105 Pyrimidine compounds
7442811 Process for the preparation of dioxane acetic acid esters
7427616 Condensed pyridines and pyrimidines with tie2 (TEK) activity
7427626 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
7427631 Metalloproteinase inhibitors
7429675 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenox- y}ethyl)phenyl]-propanoic acid
7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
7439240 Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity
7439355 Process for the production of oxabispidines
7439356 Substituted indan derivatives
7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
7442704 Amide derivatives
7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism

«ASTRAZENECA

This page contained an extended ASTRAZENECA patents listing. Click here to return to the ASTRAZENECA main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.